Faculty profile

José-Mario Capo-Chichi

Back to faculty

Assistant ProfessorDepartment of Laboratory Medicine & PathobiologyUniversity of Toronto

José-Mario Capo-Chichi

Assistant Professor

Department of Laboratory Medicine & Pathobiology

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
9 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

245

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.
Haematologica · 2026
FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells
Blood · 2025
What the VAF? A guide to the interpretation of variant allele fraction, percent mosaicism, and copy number in cancer
Molecular Cytogenetics · 2025 · senior author

All 14 publications

14 publications.

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.

Murphy T, Zhang B, Zhang T, King I, Capo-Chichi J-M, Gupta V, Maze D, McNamara CJ, Minden MD, Schimmer AD

Haematologica20266 citationsOpen Access

DOI: 10.3324/haematol.2025.287777

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells

Joana Araújo, Elvin Wagenblast, Véronique Voisin, Jessica L. McLeod, Olga I. Gan, Suraj Bansal, Liqing Jin, Amanda Mitchell, Blaise Gratton, Sarah K. Cutting, Andrea Arruda, Monica Doedens, Anthea Travas, Dennis Dong Hwan Kim, José‐Mario Capo‐Chichi, Sagi Abelson, Mark David Minden, Jean C. Y. Wang, Manuel Sobrinho Simões, Perpétua Pinto‐do‐Ó, Eric R. Lechman, John Edgar Dick

Blood202511 citationsOpen Access

DOI: 10.1182/blood.2024025886 PMID: 39841016

What the VAF? A guide to the interpretation of variant allele fraction, percent mosaicism, and copy number in cancer

Adam C. Smith, Hubert Tsui, Sila Usta, José‐Mario Capo‐Chichi

Molecular Cytogenetics20257 citationsSenior authorOpen Access

DOI: 10.1186/s13039-025-00718-3 PMID: 40629455

Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.

Perusini MA, Žáčková D, Kim T, Pagnano K, Pavlovsky C, Ježíšková I, Kvetková A, Jurček T, Kim J, Yoo Y, Yi S, Lee H, Kim KH, Chang M, Capo-Chichi JM, Medeiros JJF, Arruda A, Minden M, Zhang Z, Abelson S, Mayer J, Hwan Kim DD

Blood advances202415 citationsOpen Access

DOI: 10.1182/bloodadvances.2023012127 PMID: 38447114

The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus

Julie D. Bergeron, José‐Mario Capo‐Chichi, Hubert Tsui, Etienne Mahé, Philip Berardi, Mark David Minden, Joseph M. Brandwein, Andre C. Schuh

Current Oncology202312 citationsOpen Access

DOI: 10.3390/curroncol30120759 PMID: 38132393

Molecular genetic characterization of Philadelphia chromosome-positive acute myeloid leukemia.

Zhou Q, Zhao D, Eladl E, Capo-Chichi JM, Kim DDH, Chang H

Leukemia research2023

DOI: 10.1016/j.leukres.2022.107002 PMID: 36563650

Gastrointestinal Stromal Tumours (GISTs) with KRAS Mutation: A Rare but Important Subset of GISTs.

Mullen D, Vajpeyi R, Capo-Chichi JM, Nowak K, Wong N, Chetty R

Case reports in gastrointestinal medicine2023

DOI: 10.1155/2023/4248128 PMID: 37663588

Single cell proteogenomic sequencing identifies a relapse-fated AML subclone carrying FLT3-ITD with CN-LOH at chr13q.

Kim T, Lee H, Capo-Chichi JM, Chang MH, Yoo YS, Basi G, Ketela T, Smith AC, Tierens A, Zhang Z, Minden MD, Kim DDH

EJHaem20226 citationsOpen Access

DOI: 10.1002/jha2.390 PMID: 35846029

A t(6;14;9)(p22;q22;q34) three‐way translocation: Description of a cytogenetically visible variant t(6;9) in acute myeloid leukemia

Adam C. Smith, Dawn C. Maze, Daniel Xia, José‐Mario Capo‐Chichi, Ian F. G. King, Hassan Abdulmaoula Sibai

American Journal of Hematology20225 citations

DOI: 10.1002/ajh.26534 PMID: 35292996

Systemic mastocytosis with acute myeloid leukemia occurs from mutually exclusive clones expressing KITD816V and FLT3-ITD.

Capo-Chichi JM, Kagotho E, Nayyar R, Zhao D, Minden M, Chang H

Leukemia20212 citationsFirst author

DOI: 10.1038/s41375-020-01073-5 PMID: 33106623

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

José-Mario Capo-Chichi

Research

Latest papers

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells

What the VAF? A guide to the interpretation of variant allele fraction, percent mosaicism, and copy number in cancer

Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.

The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus

Molecular genetic characterization of Philadelphia chromosome-positive acute myeloid leukemia.

Gastrointestinal Stromal Tumours (GISTs) with KRAS Mutation: A Rare but Important Subset of GISTs.

Single cell proteogenomic sequencing identifies a relapse-fated AML subclone carrying FLT3-ITD with CN-LOH at chr13q.

A t(6;14;9)(p22;q22;q34) three‐way translocation: Description of a cytogenetically visible variant t(6;9) in acute myeloid leukemia

Systemic mastocytosis with acute myeloid leukemia occurs from mutually exclusive clones expressing KITD816V and FLT3-ITD.

Frequent collaborators

Mark Minden

Hong Chang

Adam Smith

Stefano Serra

Sagi Abelson

Dawn Maze

Hubert Tsui

Ian King

Runjan Chetty

Hassan Sibai

Jean Wang

Tracy Stockley

Zhaolei Zhang

Dennis Kim

Rajkumar Vajpeyi

Peter Sabatini

Klaudia Nowak

Vikas Gupta

Steven Chan

Rajat Kumar

Maria Perusini

Brian Leber

Qianghua Zhou

Aaron Schimmer

John Dick

Mitchell Sabloff